Objective: To investigate the association between the cervical shedding of herpes simplex virus (HSV) and HIV-1.
Introduction
Infections with herpes simplex virus (HSV) are widespread in many parts of the world, and the prevalence of HSV is particularly high in areas where HIV-1 infection is common [1] . Several studies from Africa have reported HSV seroprevalence greater than 50%, and seroprevalence exceeding 90% has been observed in some populations [1] [2] [3] [4] . HSV causes genital ulcer disease (GUD), which is associated with increased susceptibility to infection with HIV-1, and with increased HIV-1 infectivity [5] [6] [7] [8] [9] . Even in the absence of GUD, genital tract shedding of HSV and HIV-1 may be correlated. A study of women attending a reproductive health clinic in Bangui, Central African Republic, found a significant correlation between HSV DNA and HIV-1 RNA in cervicovaginal lavage specimens [4] .
If HSV shedding is associated with HIV-1 transmissibility, then the suppression of HSV reactivation could provide an important means of decreasing the spread of HIV-1 in areas where co-infection with both viruses is common. The objective of this study was to examine the association between genital tract HSV DNA, HIV-1 RNA, and HIV-1 proviral DNA (a marker for infected cells), including adjustment for the effects of CD4 lymphocyte count and plasma HIV-1 RNA.
Materials and methods

Study population and procedures
Women included in this analysis were participants in a prospective study to determine the effects of hormonal contraceptive use on genital tract shedding of HIV-1 (Wang et al., 2002, in preparation). Between September 1996 and May 1999, women starting hormonal contraceptives at Coast Provincial General Hospital in Mombasa, Kenya, were offered confidential HIV-1 counselling and testing. After informed consent, women were screened for HIV-1 using a rapid serological test (Capillus HIV-1/HIV-2; Cambridge Biotech Ltd., Galway, Ireland). Positive tests were confirmed by enzyme immunoassay (Detect; BioChem Immunosystems, Montreal, Canada). HIV-1-seropositive women were invited to participate in the study, and informed consent was obtained. The protocol was approved by the institutional review boards of the University of Nairobi and the University of Washington.
Women were interviewed about demographic, sexual, obstetric, and medical history using a standardized questionnaire. A physical examination was performed, and genital tract specimens were collected for the diagnosis of sexually transmitted diseases (STD) and the detection of HSV and HIV-1. Ten millilitres of ethyl-enediamine tetraacetic acid anticoagulated blood was collected for HSV serology (MRL Diagnostics, Cypress, CA, USA), the confirmation of HIV-1 serostatus, and lymphocyte subset analysis. The testing of Kenyan sera has confirmed the accuracy of the MRL assay (now manufactured by Focus as HerpeSelect) for the detection of HSV-2 antibodies [10] . All examinations and sample collections were performed by one of two investigators (R.S.M. or C.C.W.).
Endocervical secretions were collected by inserting a dacron swab 1 cm into the cervical os and rotating it three times. The first swab was placed in a dry cryovial for the detection of HIV-1 DNA and the quantitation of HSV DNA. The second and third swabs were placed in 1 ml freezing medium (70% RPMI, 20% fetal calf serum, 10% dimethyl sulphoxide with added penicillin, streptomycin, and amphotericin B) for the quantitation of HIV-1 RNA. Swabs were stored on ice for up to 4 h, then transferred to À708C (dry swabs) or liquid nitrogen (swabs in freezing medium). Next, cervical and vaginal secretions were collected for STD diagnosis. Women with STD or vaginitis were treated according to the Kenyan National Treatment Guidelines. All women were offered HIV/STD counselling, and latex condoms were provided in the clinic. Women with current or recent (within 2 weeks) Neisseria gonorrhoeae, Chlamydia trachomatis, or cervical ulcers were not included in our analyses, because these conditions have been independently associated with increased HIV-1 shedding [8, 11] .
Women participating in the parent study of hormonal contraceptive use and HIV-1 shedding were scheduled for follow-up examinations 1 and 2 months after initiating hormonal contraception. For this analysis, baseline data were used to explore the overall association between HSV and HIV-1 shedding. Baseline and follow-up visits at which cervical HSV was detected were included in the analysis dataset for the association between HSV and HIV-1 among HSV shedders. If cervical HSV was detected at both visits, only the first visit was included, so that multiple observations from the same individual were not used in this analysis.
Microbiology
Culture for N. gonorrhoeae was performed on modified Thayer-Martin media. The presence of C. trachomatis was determined by enzyme immunoassay (MicroTrak II; Behring Diagnostics, Cupertino, CA, USA).
Lymphocyte subsets were counted using a manual method (Cytosphere; Coulter, Hialeah, FL, USA) until September 1998, after which a semi-automated system (Zymmune; Bartels, Issaquah, WA, USA) was used.
Quantitation of HIV-1 RNA
The Gen-Probe quantitative HIV-1 assay (Gen-Probe Incorporated, San Diego, CA, USA) was used to determine the HIV-1 viral load in plasma. The lower limit of quantitation was 50 copies/ml. The quantity of HIV-1 RNA in cervical swabs was measured using a modification of the Gen-Probe assay as previously described [11] . The swabs were collected in 1 ml buffer, and the quantity of HIV-1 in copies/ml of buffer was reported as HIV-1 copies/swab. The assay was sensitive for the HIV-1 subtypes common in Kenya [12] . When the same cut-off used for plasma was applied, the lower limit of quantitation was 125 HIV-1 RNA copies/swab, because 200 ìl of swab media rather than 500 ìl of plasma were used in the assay. Lower levels of RNA are quantifiable, but with lower accuracy (Panteleeff et al., 2002, in preparation).
Detection of HIV-1 proviral DNA
Cervical dry swab samples were prepared and tested for the presence of HIV-1 proviral DNA using nested polymerase chain reaction amplification of the gag gene, as previously described [11, 13, 14] . The assay is able to detect a single copy of HIV-1 DNA [14] .
Quantitation of herpes simplex virus DNA
Cervical dry swabs were assayed for HSV DNA using a high-throughput, semi-automated, quantitative fluorescence-based polymerase chain reaction technique as previously described [15] . The assay used primers to the common region of HSV glycoprotein B, detecting both HSV-1 and HSV-2. The linear limit of quantitation for this assay was from less than 10 to 10 8 copies/ reaction.
Data analysis
Statistical analysis was performed using SPSS 10.0 (SPSS Inc., Chicago, IL, USA). Unpaired binary data were analysed using Chi-square tests. Mann-Whitney U tests were used to compare medians for unpaired continuous data. The relationship between cervical HSV DNA and HIV-1 RNA was evaluated using linear regression. Logistic regression was used to explore the association between cervical HSV and the detection of HIV-1-infected cells. Cervical HSV DNA, cervical HIV-1 RNA, and plasma HIV-1 RNA were log 10 transformed and CD4 lymphocyte counts were square root transformed to satisfy the regression modelling assumptions. HIV-1-RNA levels below the threshold for quantitation (50 copies/ml and 125 copies/ swab) were assigned values equal to half the threshold (25 copies/ml and 62.5 copies/swab, respectively) for inclusion in quantitative analyses.
Results
Among 210 HIV-1-seropositive women screened, 198 were HSV-1 seropositive and 200 were HSV-2 seropositive. The baseline characteristics of the 200 HSV-2 seropositive women are presented in Table 1 .
Cervical herpes simplex virus DNA, HIV-1 RNA, and HIV-1 proviral DNA
The detection of cervical HSV DNA was not significantly associated with HIV-1-RNA levels greater than 125 copies/swab or with the detection of HIV-1infected cells. Cervical HIV-1 RNA greater than 125 copies/swab was present in 66.7% of women (28/42) with detectable cervical HSV, and in 65.8% of women (98/149) without [odds ratio (OR) 1.04; 95% con- Higher levels of cervical HSV DNA were correlated with significantly higher levels of cervical HIV-1 RNA (Pearson's r ¼ 0.24, P ¼ 0.05; Fig. 1 ). A 1 log 10 (10fold) increase in cervical HSV was associated with a 1.35-fold increase in cervical HIV-1 RNA (95% CI 1.00-1.81; P ¼ 0.05). After adjustment for CD4 lymphocyte count and plasma HIV-1-RNA viral load, a 1 log 10 increase in cervical HSV was associated with a 1.24-fold higher cervical HIV-1-RNA level (95% CI 0.96-1.62; P ¼ 0.1).
Among women who had detectable HSV, a 1 log 10 increase in cervical HSV was associated with a 1.36fold increase in the odds of detection of HIV-1 proviral DNA (95% CI 1.05-1.75; P ¼ 0.02). This relationship was unchanged after adjustment for CD4 lymphocyte count and plasma HIV-1 RNA (OR 1.38, 95% CI 1.05-1.83; P ¼ 0.02).
Cervical herpes simplex virus and plasma HIV-1 viral load
One hundred and ninety-one women had data on plasma HIV-1-RNA levels. There was no significant difference in the median plasma HIV-1-RNA level among women with and without detectable cervical HSV DNA (5.27 versus 4.94 log 10 copies/swab; P ¼ 0.15). Furthermore, among women shedding HSV there was no correlation between the quantity of cervical HSV and the plasma HIV-1 viral load (Pearson's r ¼ 0.08; P ¼ 0.5).
Discussion
Higher levels of cervical HSV DNA were associated with higher levels of cervical HIV-1 RNA and with the more frequent detection of HIV-1-infected cells in cervical secretions. Previous authors have suggested that the association between genital tract levels of HSV and HIV-1 could be the result of systemic or local effects [4] . Immune suppression and the plasma HIV-1 viral load are important systemic factors associated with the shedding of both viruses [4, [16] [17] [18] [19] [20] . This study revealed associations between cervical HSV and HIV-1 that could not be explained solely on the basis of differences in the CD4 cell count and plasma viral load.
Local interactions between HSV and HIV-1 may provide a plausible explanation for the association between the genital shedding of the two viruses. High levels of HIV-1 RNA have been detected in genital ulcers caused by HSV-2 in men [21] . The increased expression of HIV-1 RNA in these lesions may be related to the local enhancement of HIV-1 replication Fig. 1 . The figure demonstrates a progressive increase in the median cervical HIV-1-RNA level with increasing quartiles of cervical herpes simplex virus among women with detectable cervical herpes simplex virus. Among women with no cervical herpes simplex virus (HSV) detected at the baseline visit, the median cervical HIV-1-RNA level was 2.9 log 10 copies/swab. Bars are labelled with median [interquartile range (IQR)] log 10 HIV-1-RNA copies/swab; quartile 1 (n ¼ 17), median cervical HSV 1.83 (IQR 1.57-1.95) log 10 copies/swab; quartile 2 (n ¼ 17), median cervical HSV 2.65 (IQR 2.48-3.40) log 10 copies/swab; quartile 3 (n ¼ 18), median cervical HSV 4.66 (IQR 3.81-5.67) log 10 copies/swab; quartile 4 (n ¼ 18), median cervical HSV 6.62 (IQR 6.44-6.95) log 10 copies/swab. Among the 71 women with detectable cervical HSV, one did not have a sample available for the measurement of cervical HIV-1 RNA. [22] , or to the recruitment of activated CD4 bearing cells that are the targets for HIV-1 infection into mucosal lesions caused by HSV [23] . Similar mechanisms may explain the increase in cervical mucosal HIV-1 during episodes of non-ulcerative cervical HSV shedding.
It is not clear why the association between the shedding of HSV and HIV-1 was observed only among women shedding HSV rather than in all dually infected women. A wide variability in baseline HIV-1 shedding could make it difficult to demonstrate a significant difference, because HSV is detected in only a minority of women. Alternatively, these findings could be explained by a non-causal association between the shedding of HSV and HIV-1.
There were several limitations to this study. The intermittent nature of HSV reactivation means that the collection of a single sample may fail to identify some episodes of HSV shedding [24] . Moreover, these specimens were collected from the cervical os. Because HSV infection is largely an exocervical process, this method of sample collection is likely to be less than optimal. The vulvar and peri-anal shedding of HSV were not evaluated. In addition, the HSV type was not determined in genital secretions. Finally, although the detection of sperm was infrequent, we cannot rule out the possibility that viruses detected in cervical secretions were from infected sexual partners. These limitations could have produced either an overestimation or an underestimation of the association between HSV and HIV-1 shedding.
If the non-ulcerative reactivation of HSV increases HIV-1 shedding in genital secretions, then HSV suppression could be an important means of decreasing HIV-1 infectivity, even among women without GUD. The extraordinarily high prevalence of HSV among HIV-1-seropositive women in this cohort highlights the need for additional prospective studies of the relationship between HSV and HIV-1 shedding.
